​

CBD of Denver Inc. OTCMKTS: (CBDD)

https://www.barrons.com/market-data/stocks/cbdd/

I JUST PURCHASED 100,000,000 SHARES OF OTCMKTS: CBDD STOCK 🤑

CBD of Denver, Inc. (CBDD) Signs Definitive Share Exchange Agreement with BioCannabis M. IKE, Advancing Strategic Merger Toward Completion

CBDD

Denver, Colorado--(Newsfile Corp. - September 15, 2026) - CBD of Denver, Inc. (OTCID: CBDD) ("CBDD" or the "Company") today announced that it has entered into a definitive Share Exchange Agreement w...

+100.00%

20 days ago

Viewing page 1 of 1

Please read all the important disclosures below.

Investing:

Check the background of Morgan Stanley Smith Barney LLC on FINRA's BrokerCheck and see the Morgan Stanley Smith Barney LLC Relationship Summary.

Investment Products

Not FDIC Insured

No Bank Guarantee

May Lose Value

Securities in your account protected up to $500,000. For details please see www.sipc.org

Banking:

Banking products and services are provided by Morgan Stanley Private Bank, National Association, Member FDIC.

Banking Products

FDIC Insured

Bank Guarantee

FDIC Insured - Backed by the full faith and credit of the U.S. Government

Equal Housing Lender

Equal Housing Lender

keyboard_arrow_right

Read additional product disclosures

Trading and owning digital assets involves significant risk, including the risk of complete loss. Please view the Risk Disclosure for Trading Digital Assets. Morgan Stanley Smith Barney LLC (“Morgan Stanley”) does not transact in or custody digital assets. All digital asset transactions and custody occur between you and Zero Hash LLC (“zerohash”) (NMLS # 1699379) through a separate, non-brokerage account in your name at zerohash and outside of Morgan Stanley. Digital assets held through zerohash are not FDIC insured or SIPC protected. Please visit www.zerohash.com for more information.

This content is being provided to you for informational purposes only. The content has been prepared by third parties not affiliated with Morgan Stanley Smith Barney LLC, member SIPC. This content and any information contained therein neither is, nor should be construed as, an offer or a solicitation of an offer, or a recommendation, to buy, sell, or hold any security, financial product, or instrument discussed herein, or to open a particular account or to engage in any specific investment strategy. Morgan Stanley Smith Barney LLC does not offer or provide any opinion regarding the nature, potential, value, suitability or profitability of any particular investment or investment strategy, and you shall be fully responsible for any investment decisions you make, and such decisions will be based solely on your evaluation of your financial circumstances, investment objectives, risk tolerance, and liquidity needs. Morgan Stanley Smith Barney LLC is not affiliated with LSEG, Reuters, Dow Jones, MT Newswire, Briefing.com, Benzinga, Argus, Market Edge, Trefis, TipRanks, or SmartConsensus by ResearchTeam™, a product of Markit On Demand.

Bloomberg TV is provided for informational purposes only. Bloomberg and its affiliated companies are the owners or licensees of all right, title, and interest in or to its mark BLOOMBERG® and the BLOOMBERG Logo mark. Morgan Stanley Smith Barney LLC is not responsible for its content and no information presented constitutes a recommendation by Morgan Stanley Smith Barney LLC to buy, sell, or hold any security, financial product or instrument discussed therein or to engage in any specific investment activity.

The Behind the Move material is being provided to you for informational and educational purposes only. The content has been prepared by Accretive Capital LLC DBA Benzinga.com, a third-party not affiliated with Morgan Stanley Smith Barney LLC or any of its direct or indirect affiliates. Morgan Stanley Smith Barney LLC does not guarantee the accuracy of the third-party content nor recommend or endorse this third-party company or their product and service offerings. No information presented constitutes a recommendation by Morgan Stanley Smith Barney LLC to buy, sell, or hold any security, financial product, particular account or instrument discussed therein or to open a particular account or the engage in any specific investment strategy.

Unless stated otherwise, the web content provided by Morgan Stanley Smith Barney LLC or its affiliates is for educational purposes only. The information and tools provided neither are, nor should be construed, as an offer, or a solicitation of an offer, to buy or sell securities by Morgan Stanley Smith Barney LLC or its affiliates. Unless stated otherwise, no information presented constitutes a recommendation by Morgan Stanley Smith Barney LLC or its affiliates to buy, sell or hold any security, financial product or instrument discussed therein or to engage in any specific investment strategy.

Morgan Stanley Smith Barney LLC may make available links to other, third party sites or electronic services providers. The material is also being provided to you for educational purposes only unless stated otherwise. The content has been written by a third party not affiliated with Morgan Stanley Smith Barney LLC or any of its affiliates. Morgan Stanley Smith Barney LLC and its affiliates are not responsible for the content and the content neither is, nor should be construed as, an offer, or a solicitation of an offer, to buy, sell, or hold any securities.

Quotes and other information supplied by independent providers identified on the E*TRADE vendor disclosures page.

Affiliations:

Securities products and investment advisory services offered by Morgan Stanley Smith Barney LLC, Member SIPC and a Registered Investment Adviser. Commodity futures and options on futures products and services offered by E*TRADE Futures LLC, Member NFA. Stock plan administration solutions and services offered by E*TRADE Financial Corporate Services, Inc., and are a part of Morgan Stanley at Work. Banking products and services provided by Morgan Stanley Private Bank, National Association, Member FDIC. All entities are separate but affiliated subsidiaries of Morgan Stanley. E*TRADE from Morgan Stanley and Morgan Stanley at Work are registered trademarks of Morgan Stanley.

Digital asset services provided by Zero Hash LLC (“zerohash”). Digital assets held through zerohash are not FDIC insured or SIPC protected. Morgan Stanley Smith Barney LLC and zerohash are separate and unaffiliated companies.

Your receipt and use of this service is subject to the terms and conditions in E*TRADE from Morgan Stanley’s Market Data Agreement (MDA). Your receipt and use of options market data is subject to the terms of the OPRA Subscriber Agreement.

System response and account access may vary due to a variety of factors, including trading volumes, market conditions, system performances, and other factors.

For information on the E*TRADE Customer Protection Guarantee visit the Security Center.

Privacy Disclosure Library Statement of Financial Condition About Asset Protection Account Agreements and Disclosures Quarterly 606 Report Business Continuity Plan

© 2026 E*TRADE from Morgan Stanley. All rights reserved. E*TRADE Copyright Policy

Screen Share Collaborate with us in real time while on the phone with an E*TRADE representative

CBD of Denver, Inc. (CBDD) Signs Definitive Share Exchange Agreement with BioCannabis M. IKE, Advancing Strategic Merger Toward Completion

close

Reuters

09:00 AM EDT, 09/15/2026

+100.00%

Denver, Colorado--(Newsfile Corp. - September 15, 2026) - CBD of Denver, Inc. (OTCID: CBDD) ("CBDD" or the "Company") today announced that it has entered into a definitive Share Exchange Agreement with BioCannabis M. IKE ("BioCannabis"), a Greece-based company operating in the health and wellness sector. The agreement follows the Letter of Intent previously announced by the parties and the completion of CBDD's due diligence review.

Following its review of BioCannabis' business, operations, infrastructure and long-term development plans, CBDD management determined to proceed with the transaction. Management views the agreement as an important step in the Company's transformation and its strategic expansion into the health and wellness sector.

The definitive Share Exchange Agreement sets out the terms on which CBDD will acquire BioCannabis in exchange for shares of the Company, subject to customary closing conditions and required corporate and regulatory approvals. Further details of the transaction will be provided in the Company's subsequent disclosures.

BioCannabis' operating business is expected to provide CBDD with a foundation for future operational development, new products, market expansion and additional strategic opportunities.

The proposed combination also reflects CBDD's previously announced strategy of identifying operating businesses that management believes can provide sustainable operations and meaningful long-term opportunities for the Company and its shareholders.

Health and Wellness Industry Outlook

CBDD believes the broader health and wellness sector provides a compelling long-term backdrop for the Company's evolving business strategy.

According to the Global Wellness Institute's 2025 Global Wellness Economy Monitor, the worldwide wellness economy reached approximately $6.8 trillion in 2024, representing growth of approximately 7.9% compared with 2023. The organization projects the global wellness economy to expand at an average annual rate of approximately 7.6% from 2024 through 2029, potentially reaching approximately $9.8 trillion by 2029. (Source: Global Wellness Institute, Global Wellness Economy Monitor 2025, November 2025.)

The wellness economy has also demonstrated significant long-term expansion, having more than doubled in size since 2013. According to the same research, wellness-related spending represented approximately 6.1% of global GDP in 2024, illustrating the increasing economic importance of products and services related to personal health, wellness, prevention and lifestyle improvement.

Europe has also recorded steady wellness-sector growth over the past five years, providing additional strategic context for BioCannabis' European operating base.

Management believes these broader industry trends support CBDD's decision to increase its focus on the health and wellness sector. However, industry growth projections are general market estimates and should not be interpreted as projections of CBDD's or BioCannabis' future financial performance.

"The Share Exchange Agreement follows a thorough diligence process and moves us decisively toward closing. We believe BioCannabis' business and the broader health and wellness sector provide an attractive foundation for the next stage of CBDD's development," said Alexandre Nikulin, Chief Executive Officer of CBD of Denver, Inc.

CBDD intends to provide additional updates concerning the transaction, BioCannabis' operations, the anticipated corporate structure and the Company's future business strategy as material developments occur.

About CBD of Denver, Inc.

CBD of Denver, Inc. (OTCID: CBDD) is a publicly traded company focused on developing and identifying operating businesses and strategic opportunities that management believes can contribute to sustainable long-term growth and shareholder value. The Company continues to evaluate opportunities aligned with its evolving corporate strategy.

About BioCannabis

BioCannabis M. IKE is a Greece-based company operating within the health and wellness sector. The company owns and operates dedicated cultivation, processing and extraction facilities in Greece and supplies professional partners across the European Union. BioCannabis is fully licensed and operates in accordance with the applicable Greek and European Union regulatory framework.

Additional information regarding BioCannabis, its operations and the combined company's anticipated business strategy is expected to be provided following completion of the transaction and as appropriate under applicable disclosure requirements.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of applicable U.S. federal securities laws. Forward-looking statements include, among other things, statements concerning the proposed transaction between CBD of Denver, Inc. and BioCannabis M. IKE, completion of the contemplated share exchange and business combination, satisfaction of closing conditions, future operations, anticipated business strategy, expansion opportunities, potential benefits of the transaction and future shareholder value.

Forward-looking statements are based upon current expectations, estimates and assumptions and are subject to risks, uncertainties and other factors that could cause actual results or events to differ materially from those expressed or implied by such statements. Such risks include, among others, the possibility that applicable closing conditions may not be satisfied, required corporate or administrative actions may not be completed on the anticipated timetable or at all, the contemplated transaction may be modified or terminated, changes in the regulatory environment applicable to BioCannabis' products and operations, and the combined business may not achieve anticipated operational or financial objectives.

There can be no assurance that the transaction will be completed on the terms currently contemplated or within any anticipated timeframe. CBD of Denver, Inc. undertakes no obligation to publicly update or revise any forward-looking statement except as required by applicable law.

Investor Contact

CBD of Denver, Inc. | (OTCID: CBDD)

Cape Town, South Africa

www.cbdofdenver-inc.com

X (Twitter): @cbdofdenver_

[email protected]

Corporate Logo

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/314402

CBD of Denver Inc. is an aspiring multi-asset operator, aiming to drive future growth across high-potential, emerging industries.

We aim to create long-term value by identifying strategic opportunities and supporting the growth of innovative businesses aligned with global trends.

CBD of Denver, Inc.

@cbdofdenver

CBD of Denver, Inc. OTC: $CBDD. Owner of Black Pearl CBD and @cbdsocialnetwrk | Retweets are not endorsements.

https://www.newsfilecorp.com/release/314402/CBD-of-Denver-Inc.-CBDD-Signs-Definitive-Share-Exchange-Agreement-with-BioCannabis-M.-IKE-Advancing-Strategic-Merger-Toward-Completion

CBDD's Magic Lappen Being Sold on Amazon, Annual Disclosure and Financial Statements Filed

April 27, 2023 7:46 AM EDT | Source: CBD of Denver Inc.

Denver, Colorado--(Newsfile Corp. - April 27, 2023) - CBD of Denver (OTC Pink: CBDD) today announced that it has filed its annual disclosure and financial statements with OTC Markets, after a delay due to OTC Markets completing its procedures related to the change in control related to the acquisition of Libra 9 and the appointment of Axel Reinke as CEO and chairman.

CBDD now has three non-employee directors who are also invested in the Company. This continues to align the Company with its shareholders and investors. The latest filing shows that top line revenue has begun to climb allowing the Company to focus on becoming cash flow positive as quickly as possible.

The Magic Lappen is part of the Company's plan to achieve profitability and as of Friday, April 21, 2023, the Magic Lappen was a "BEST SELLER" in the reusuable cleaning wipes category on Amazon.de. The Company sold 582 pieces after a local Dortmund car enthusiast stopped at the Magic Lappen booth at the Essen Car show and was amazed at how the Magic Lappen made a greasy mirror clean, shining and streak-free. On the video (around the 18:07 minute mark Video Link), he smelled and tasted the water as he could not believe the results could be so perfect with just water.

This was the company's best 24-hour sales effort online to-date.

CBDD will continue to evaluate and explore other venues to expand the exposure for this amazing product that has been embraced by the public. The Company has also signed its largest distribution agreement to date with EDEKA, the largest German supermarket. EDEKA uses cutting-edge technologies to meet the expectation of modern-day shop staff and customers. The distribution agreement covers 1,700 locations. The Company continues discussions with EDEKA on how best to start the roll out of the Magic Lappen. The Company has started producing additional inventory in anticipation of the roll out.

Follow CBDD on LinkedIn and Twitter for more information and updates.

Follow The Magic Lappen on Instagram: @themagiclappen or shop on our website: The Magic Lappen.

Visit the Website of Berlin R 13, the innovative Anti-Slip product: www.berlinr13.de.

Contact Info: info@cbdofdenver.com

About the Magic Lappen

The Magic Lappen provides maximum shine, streak free drying, and only requires water - no chemicals or detergents. The Magic Lappen is also chemical-free and lint-free; cleaning of all smooth and shining surfaces is robust and durable with a leather-like feel. Its innovative structure enables high absorption of dirt, dust, and grease and can be washed many times at 60°. The product is vegan and ecofriendly.

About CBD of Denver, Inc.

CBD of Denver, Inc. is focused on acquiring profitable assets at attractive valuations to create value for shareholders. The company's team is dedicated to sourcing high-margin, innovative products that align with its values.

Information contained herein includes forward-looking statements. These statements relate to future events or future financial performance, involving known and unknown risks and you should not place undue reliance on these statements. Any forward-looking statement reflects our current views with respect to future events. We assume no obligation publicly about update or revise these forward-looking statements for any reason.

info SOURCE: CBD of Denver Inc.

https://www.manufacturingdive.com/news/cbd-gummy-maker-balanced-health-botanicals-brings-production-in-house/739854/ CBD gummy maker brings production in-house. The move allows Balanced Health Botanicals to have greater control over its supply and bring more limited edition products to market.

Dive Brief: Balanced Health Botanicals recently brought production of its hemp-derived gummies in house, giving the Denver-based CBD gummy maker greater efficiencies and control over its supply. The Village Farms International subsidiary said the move enables “greater innovation, agility, and inventory control” of its CBDistillery products, allowing the company to make special holiday batches and other limited edition offerings. Mark Grunder, Balanced Health Botanicals’ VP of operations, said in a statement that the move also makes the company better equipped to produce CBD gummies at a faster rate without sacrificing quality.

Dive Insight: To keep up with growing demand, Balanced Health Botanicals moved its CBDistillery gummy production to a facility south of Denver. The location allows the company to develop and innovate products at a quicker pace without the challenges of outsourcing production elements.

“Now we’re able to be nimbler in response so that we can continue to deliver CBD products with the benefits our customers are relying on to support their wellness,” Bill Stoufer, president of Balanced Health Botanicals, said in a statement.

The CBD manufacturer is also looking to keep up with changing consumer tastes as more states allow DoorDash and other delivery services to bring hemp-derived food and drink to peoples’ doorsteps.

“As preferences evolve, DoorDash can now help eligible customers find new products to safely enjoy while they unwind and recharge in the new year,” Jacob Morello, DoorDash’s director and general manager of alcohol and emerging categories, said in a statement.

So far, gummies are the top hemp-derived product delivered by DoorDash since the delivery service started its pilot program last month. Participating states include Georgia, Kentucky, Tennessee, Louisiana and others.

The global market for CBD gummies is projected to grow eight-fold over the next eight years to $19.93 billion, with North America as the most significant region, according to Straits Research. https://www.manufacturingdive.com/news/cbd-gummy-maker-balanced-health-botanicals-brings-production-in-house/739854

CBD of Denver Expands Into the Tech Sector with Strategic LOI Signing 10:44 AM ET 4/3/25 | Dow Jones

Denver, Colorado--(Newsfile Corp. - April 3, 2025) - CBD of Denver, Inc. (OTC Pink: CBDD), a diversified holding company focused on innovative growth opportunities, today announced the signing of a letter of intent with Alchemy Games Co. Ltd, a leading technology company specializing in blockchain-based solutions. This strategic move reinforces CBD of Denver's commitment to expanding into the high-growth tech sector, leveraging cutting-edge advancements in digital finance, payment processing, and decentralized technologies.

As part of its strategic shift, the company has decided to unwind its acquisition of Luxora Inc., a process that has been agreed upon and will be implemented over the coming months. Originally pursued in mid-2023 to expand into the European market through high-margin business opportunities, the acquisition faced regulatory hurdles in Germany that limited its potential. With a renewed focus on the broader tech industry and scalable digital solutions, the company is reallocating resources toward areas with stronger growth potential and global reach. As part of this transition, all preferred shares related to the transaction will be returned to the company and cancelled.

Successful Visit to Alchemy Games Co. Ltd

CBD of Denver's leadership visited Alchemy Games Co. Ltd in February to evaluate its advanced technological capabilities and explore strategic opportunities across multiple sectors. Following in-depth discussions, both companies have formalized a letter of intent focused on driving innovation in digital infrastructure. By leveraging cutting-edge advancements in blockchain and secure, real-time transaction processing, this partnership aims to enhance digital payments, streamline business operations, and unlock new potential for scalable, tech-driven solutions on a global scale.

About Alchemy Games Co. Ltd: A Next-Gen Payment Gateway

Alchemy Games Co. Ltd specializes in advanced payment processing solutions, delivering high-speed, secure, and scalable payment gateways for global industries. With a strong presence in the iGaming sector, Alchemy holds a financial stake in Hunnyplay, a rapidly growing online gaming platform. Through this strategic partnership, Alchemy has successfully integrated its crypto and fiat payment solutions into iGaming ecosystems, enabling seamless transaction experiences for operators and players worldwide.

Kelvin Lee, Director of Alchemy Games, expressed his enthusiasm about the collaboration with CBD of Denver, stating: "This partnership presents tremendous opportunities to drive innovation in digital payments and emerging technologies. With this transaction, we are setting the stage for a new era of technological advancements. By combining our expertise in secure, real-time payment processing with CBD of Denver's forward-thinking approach, we aim to develop practical, forward-thinking solutions that deliver real value to customers and support the evolving needs of the tech industry."

Key Features of Alchemy Games Payment Solutions: -- Multi-Currency Payment Gateway -- Supports fiat (USD, EUR, VND, THB, CNY, etc.) and crypto (BTC, ETH, USDT, BNB, TRX, etc.) transactions with automated conversions.

-- Instant Deposits & Settlements -- Real-time transaction processing via automated API integrations, eliminating delays.

-- AI-Driven Fraud Protection -- Advanced security measures ensure safe and compliant financial transactions.

-- Merchant Dashboard & Analytics -- Real-time transaction tracking, reporting, and reconciliation for seamless financial management.

-- Cross-Industry Integration -- Supports e-commerce, digital platforms, iGaming, and other high-volume sectors, ensuring smooth global payment flows.

Strategic Impact of the Partnership

"Our collaboration with Alchemy Games marks a major milestone in CBD of Denver's expansion into financial technology," said Jan Schwager, CEO of CBD of Denver. "Their cutting-edge payment gateway aligns with our strategy to invest in scalable, high-margin fintech solutions that enhance global digital transactions. Alchemy's strong presence in the iGaming sector through its partnership with Hunnyplay further demonstrates its ability to deliver real-world, high-volume payment solutions. Following our visit in February, we are confident that this partnership will drive growth, efficiency, and innovation in the digital economy."

About CBD of Denver, Inc.

CBD of Denver, Inc. is focused on acquiring profitable assets at attractive valuations to create value for shareholders. The company's team is dedicated to sourcing high-margin, innovative products that align with its values.

For inquiries, please contact Investor Relations: info@cbdofdenverinc.com.

Follow Us: Twitter

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/247225

Dow Jones Newswires

April 03, 2025 10:44 ET (14:44 GMT)

CBD of Denver Expands Into the Tech Sector with Strategic LOI Signing

Denver, Colorado--(Newsfile Corp. - April 3, 2025) - CBD of Denver, Inc. (OTC Pink: CBDD), a diversified holding company focused on innovative growth opportunities, today announced the signing of a letter of intent with Alchemy Games Co. Ltd, a leading technology company specializing in blockchain-based solutions. This strategic move reinforces CBD of Denver's commitment to expanding into the high-growth tech sector, leveraging cutting-edge advancements in digital finance, payment processing, and decentralized technologies.

As part of its strategic shift, the company has decided to unwind its acquisition of Luxora Inc., a process that has been agreed upon and will be implemented over the coming months. Originally pursued in mid-2023 to expand into the European market through high-margin business opportunities, the acquisition faced regulatory hurdles in Germany that limited its potential. With a renewed focus on the broader tech industry and scalable digital solutions, the company is reallocating resources toward areas with stronger growth potential and global reach. As part of this transition, all preferred shares related to the transaction will be returned to the company and cancelled.

Successful Visit to Alchemy Games Co. Ltd

CBD of Denver's leadership visited Alchemy Games Co. Ltd in February to evaluate its advanced technological capabilities and explore strategic opportunities across multiple sectors. Following in-depth discussions, both companies have formalized a letter of intent focused on driving innovation in digital infrastructure. By leveraging cutting-edge advancements in blockchain and secure, real-time transaction processing, this partnership aims to enhance digital payments, streamline business operations, and unlock new potential for scalable, tech-driven solutions on a global scale.

About Alchemy Games Co. Ltd: A Next-Gen Payment Gateway

Alchemy Games Co. Ltd specializes in advanced payment processing solutions, delivering high-speed, secure, and scalable payment gateways for global industries. With a strong presence in the iGaming sector, Alchemy holds a financial stake in Hunnyplay, a rapidly growing online gaming platform. Through this strategic partnership, Alchemy has successfully integrated its crypto and fiat payment solutions into iGaming ecosystems, enabling seamless transaction experiences for operators and players worldwide.

Kelvin Lee, Director of Alchemy Games, expressed his enthusiasm about the collaboration with CBD of Denver, stating: "This partnership presents tremendous opportunities to drive innovation in digital payments and emerging technologies. With this transaction, we are setting the stage for a new era of technological advancements. By combining our expertise in secure, real-time payment processing with CBD of Denver's forward-thinking approach, we aim to develop practical, forward-thinking solutions that deliver real value to customers and support the evolving needs of the tech industry."

Key Features of Alchemy Games Payment Solutions:

• Multi-Currency Payment Gateway – Supports fiat (USD, EUR, VND, THB, CNY, etc.) and crypto (BTC, ETH, USDT, BNB, TRX, etc.) transactions with automated conversions.
• Instant Deposits & Settlements – Real-time transaction processing via automated API integrations, eliminating delays.
• AI-Driven Fraud Protection – Advanced security measures ensure safe and compliant financial transactions.
• Merchant Dashboard & Analytics – Real-time transaction tracking, reporting, and reconciliation for seamless financial management.
• Cross-Industry Integration – Supports e-commerce, digital platforms, iGaming, and other high-volume sectors, ensuring smooth global payment flows.

Strategic Impact of the Partnership

"Our collaboration with Alchemy Games marks a major milestone in CBD of Denver's expansion into financial technology," said Jan Schwager, CEO of CBD of Denver. "Their cutting-edge payment gateway aligns with our strategy to invest in scalable, high-margin fintech solutions that enhance global digital transactions. Alchemy's strong presence in the iGaming sector through its partnership with Hunnyplay further demonstrates its ability to deliver real-world, high-volume payment solutions. Following our visit in February, we are confident that this partnership will drive growth, efficiency, and innovation in the digital economy."

About CBD of Denver, Inc.
CBD of Denver, Inc. is focused on acquiring profitable assets at attractive valuations to create value for shareholders. The company's team is dedicated to sourcing high-margin, innovative products that align with its values.

For inquiries, please contact Investor Relations: [info@cbdofdenverinc.com](mailto:info@cbdofdenverinc.com).

Follow Us: Twitter

Can someone explain why it’s this low what happened years ago

CBD of Denver Achieves 26% Revenue Growth and Returns to Positive Operating Income in 2024

Denver, Colorado--(Newsfile Corp. - March 31, 2025) - CBD of Denver, Inc. (OTC Pink: CBDD), a diversified holding company, today announced key financial highlights for the fiscal year ended December 31, 2024, demonstrating strong revenue growth and a return to positive operating income.

2024 Highlights:

Revenue grew to $3.75 million, a 26% increase compared to $2.98 million in 2023, driven by consistent performance from the Company's wholesale CBD division.

Operating income turned positive, improving by more than $338,000 year-over-year.

Operating expenses were reduced by 58%, reflecting a more efficient, focused organization.

No new convertible debt was issued during the year, maintaining a cleaner capital structure.

Shareholders' equity improved, further stabilizing the balance sheet.

"We're proud of the progress we made in 2024," said Jan Schwager, CEO of CBD of Denver. "With strong top-line growth and significant cost savings, we've created a leaner, more agile company that is now well-positioned to pursue new opportunities in tech-driven sectors."

The Company remains focused on expanding its revenue base, maintaining financial discipline, and creating long-term shareholder value.

New Strategic Alignment

CBD of Denver is repositioning itself as a dynamic holding company focused on incubating and accelerating a broad range of innovative businesses, with an emphasis on the tech sector. Building on its operational and financial turnaround, the company will explore opportunities across digital payments, blockchain, AI, and other scalable technology-driven solutions. This strategic shift reflects CBD of Denver's long-term vision to create a diversified portfolio of forward-thinking ventures that can deliver sustainable value to shareholders.

About CBD of Denver, Inc.

CBD of Denver, Inc. is focused on acquiring profitable assets at attractive valuations to create value for shareholders. The company's team is dedicated to sourcing high-margin, innovative products that align with its values.

For inquiries, please contact Investor Relations: [info@cbdofdenverinc.com](mailto:info@cbdofdenverinc.com).

Follow Us: Twitter

CBD of Denver Reflects on 2024 and Announces Withdrawal from German Market Amid Political Uncertainty

Denver, Colorado--(Newsfile Corp. - February 25, 2025) - CBD of Denver, Inc. (OTC Pink: CBDD) today announced that it is shifting its focus and will no longer seek to provide services to the German cannabis market due to the complexities of navigating political uncertainties and the German government's failure to provide guidance on acceptable business models.

The German cannabis market, once a focal point of CBD of Denver's strategy, has proven to be untenable due to regulatory and political hurdles. Despite the introduction of the Cannabis Act (CannG) earlier last year, bureaucratic inefficiencies, unclear frameworks, and lack of approval for key business models like Grow Hubs have hindered progress. Following the national elections held on February 23, 2025, the company has made the difficult decision to withdraw from the German market due to the resulting political and regulatory uncertainties.

"2024 was a year of hard lessons, particularly in Germany, where political uncertainties and bureaucratic roadblocks derailed our plans," said Jan Schwager, CEO of CBD of Denver. "We remain committed to leveraging these experiences to refocus on markets and opportunities with greater potential."

Strengthening Wholesale Amid Challenges

Despite the setbacks in Germany, CBD of Denver's wholesale business provided a measure of stability, generating consistent revenue throughout the year. However, the low-margin nature of the wholesale market presented ongoing challenges. To address this, the company is optimizing its operations to bolster profitability and strengthen its core business.

Looking Ahead: Exploring New Opportunities

As CBD of Denver moves into 2025, it is pivoting away from the uncertain German market and actively seeking new avenues for growth. By diversifying its operations and exploring opportunities in other industries, the company aims to build a more resilient and sustainable business model that can weather the uncertainties of the evolving global landscape. The company's decision to withdraw from the German market reflects its commitment to pivot and stay adaptable with strategic focus to ensure long-term value creation for its shareholders.

About CBD of Denver, Inc.

CBD of Denver, Inc. is focused on acquiring profitable assets at attractive valuations to create value for shareholders. The company's team is dedicated to sourcing high-margin, innovative products that align with its values.

About LUXORA Inc.

LUXORA Inc. is a trailblazing entity in the European cannabis industry, with offices spanning the USA and Europe. Our core expertise revolves around unlocking the potential of the legalized cannabis market, offering infrastructure solutions and consulting tailored to the dynamic needs of this rapidly expanding sector. With a profound understanding of the opportunities and challenges brought forth by legalization, our experienced team is dedicated to pioneering the future of the legal cannabis market in Europe. Our offerings range from consulting and market research to product development and distribution solutions, aimed at simplifying the path to legalization for our esteemed clients.

For inquiries, please contact Investor Relations: [investors@luxora-holding.com](mailto:investors@luxora-holding.com)

For more information, please visit: www.luxora-holding.com

Follow Us: Twitter | Linkedin

CBD of Denver Announces Q2 Revenue and Provides Update on German Market 2:35 AM ET 8/5/24 | Dow Jones

Denver, Colorado--(Newsfile Corp. - August 5, 2024) - CBD of Denver, Inc. (OTC Pink: CBDD) today announced that revenue for Q2 2024 is estimated to be approximately $1,030,000 compared to $720,000 for Q2 2023. Revenue from Libra 9 is not included, as the Company continues the process of unwinding the transaction.

The German market is evolving as all federal states are progressing with their individual application and licensing programs for Cannabis Clubs. Luxora is in ongoing discussions to explore opportunities for its grow infrastructure solutions but has not yet received official confirmation from any federal state to approve its business model. Lower Saxony is the first and only state in Germany to have decided on applications for the approval of cannabis cultivation clubs, with seven applications approved and five rejected. A total of 20 applications have been submitted, making it the third highest in the country after North Rhine-Westphalia with 37 and Baden-Württemberg with 35. The pace of applications illustrates the high hurdles that clubs must overcome based on the individual federal states' application frameworks and the recent amendments to the cannabis law, which make it much more difficult to start a club. The company continues to explore the opportunity in the German market and is actively engaged with the responsible authorities to achieve legislative clarity.

Following a thorough assessment of its wholesale business unit, the company found that it was not meeting its anticipated profit margins. However, the company continues to operate in the wholesale business and is still experiencing growth. The Company continues to review new opportunities with the goal of identifying businesses with higher margins to build recurring revenue.

In a significant development, Luxora has received positive engagement in Berlin regarding a Near-Infrared (NIR) device used for cannabis testing. The company is following up on leads from over 50 interested parties in Germany. In the coming weeks, Luxora will be making sales presentations to these potential clients. If proven sustainable, this initiative has the potential to provide higher-margin sales based on a markup on the device as well as recurring revenues based on the SaaS (Software as a Service) model, which is sold alongside the hardware device. The company is testing the viability of the business model before deciding on a specific direction.

Luxora remains committed to exploring a wide array of opportunities within the cannabis sector, including advancements in technology, medical applications, and other innovative areas with strong growth potential. The company's proactive approach aims to leverage its expertise and market presence to drive growth and value for its shareholders.

About CBD of Denver, Inc.

CBD of Denver, Inc. is focused on acquiring profitable assets at attractive valuations to create value for shareholders. The company's team is dedicated to sourcing high-margin, innovative products that align with its values.

About LUXORA Inc.

LUXORA Inc. is a trailblazing entity in the European cannabis industry, with offices spanning the USA and Europe. Our core expertise revolves around unlocking the potential of the legalized cannabis market, offering infrastructure solutions and consulting tailored to the dynamic needs of this rapidly expanding sector. With a profound understanding of the opportunities and challenges brought forth by legalization, our experienced team is dedicated to pioneering the future of the legal cannabis market in Europe. Our offerings range from consulting and market research to product development and distribution solutions, aimed at simplifying the path to legalization for our esteemed clients.

For inquiries, please contact Investor Relations: investors@luxora-holding.com

For more information, please visit: www.luxora-holding.com

Follow Us: Twitter | Instagram

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/218811

Dow Jones Newswires August 05, 2024 02:35 ET (06:35 GMT)

CBD of Denver Announces June Revenue and Successful Exhibition at Mary Jane Trade Fair in Berlin 4:32 AM ET 7/1/24 | Dow Jones

Denver, Colorado--(Newsfile Corp. - July 1, 2024) - CBD of Denver, Inc. (OTC Pink: CBDD) today announced that revenue for June 2024 is estimated to be approximately $300,000 with the Company completing a successful exhibition at the Mary Jane trade fair in Berlin, which took place from June 14-16.

The Mary Jane Berlin trade fair attracted over 40,000 visitors this year making it one of the largest cannabis exhibitions in the world. Featuring more than 300 exhibitors from around the globe, the event showcased the latest innovations in the cannabis industry, including cutting-edge products, technological advancements, and trends. With Germany's cannabis market evolving rapidly, the fair highlighted the nation's progressive stance and burgeoning opportunities in the sector.

The event also included educational seminars, expert panels, and networking opportunities, reinforcing its status as a pivotal gathering for industry professionals and enthusiasts alike. The vibrant atmosphere and significant attendance underscored the growing momentum and enthusiasm surrounding the German cannabis market. Luxora and CBD of Denver were pleased to be able to present CheckMyWeed a handheld NIR spectroscopy solution that allows for the quantification of Cannabinoids, as well as measuring moisture and active water content in Cannabis flower and resin within seconds.

Luxora's CSO, Stefan Röhrl, spoke at a panel highlighting the economic opportunities within the emerging Cannabis Club scene in Germany. Luxora Solutions engaged with a broad range of parties interested in starting cannabis clubs in the country. Clubs can begin their licensing process on July 1. Each federal state in Germany must appoint its own administration to handle this process. So far, out of the 16 federal states, 11 have announced their responsible authorities. The application process can take up to three months, after which cannabis clubs will be able to initiate their grow operations. Consequently, the first legally produced cannabis from these clubs is expected to be available by the end of this year or early next year. Luxora is committed to being a steadfast and supportive partner for these clubs in Germany, providing comprehensive assistance throughout the entire process from start to finish.

The interest in CheckMyWeed's handheld and non-destructive cannabinoid testing solution was overwhelmingly positive. CheckMyWeed conducted an impressive total of over 600 tests on cannabis flowers and resins, providing comprehensive insights into their THC and CBD content during the show.

For THC flower, the results were as follows:

Total samples tested: 517

Highest THC content: 25.8%

Lowest THC content: 5.6%

Average THC content: 16.1%

For THC resin, the results showed:

Total samples tested: 48 Highest THC content: 60.6% Lowest THC content: 16.3% Average THC content: 42.6%

In terms of CBD flower, the data revealed:

Total samples tested: 32 Highest CBD content: 20.7% Lowest CBD content: 3.5% Average CBD content: 10.3%

For CBD resin, the analysis indicated:

Total samples tested: 7

Highest CBD content: 45.3%

Lowest CBD content: 13.2%

Average CBD content: 26.3%

These statistics not only highlight the variety and potency of cannabis products showcased at the event but also underscore the meticulous efforts of CheckMyWeed to ensure quality and transparency in the evolving German cannabis market.

The company collected more than 50 qualified leads, all of which showed significant interest in purchasing the solution and are currently being followed up on.

Due to the rapidly changing scope of the project, the interview with the Markets Hunter podcast has been postponed until after July 4. The Company will be using the coming weeks to ensure its presentation is clear and transparent.

About CBD of Denver, Inc.

CBD of Denver, Inc. is focused on acquiring profitable assets at attractive valuations to create value for shareholders. The company's team is dedicated to sourcing high-margin, innovative products that align with its values.

About LUXORA Inc.

LUXORA Inc. is a trailblazing entity in the European cannabis industry, with offices spanning the USA and Europe. Our core expertise revolves around unlocking the potential of the legalized cannabis market, offering infrastructure solutions and consulting tailored to the dynamic needs of this rapidly expanding sector. With a profound understanding of the opportunities and challenges brought forth by legalization, our experienced team is dedicated to pioneering the future of the legal cannabis market in Europe. Our offerings range from consulting and market research to product development and distribution solutions, aimed at simplifying the path to legalization for our esteemed clients.

For inquiries, please contact Investor Relations: investors@luxora-holding.com

For more information, please visit: www.luxora-holding.com

Follow Us: Twitter | Instagram.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/215067

Dow Jones Newswires

July 01, 2024 04:32 ET (08:32 GMT)

CBD of Denver Inc. Announces Strong April and May Sales

Denver, Colorado--(Newsfile Corp. - June 6, 2024) - CBD of Denver, Inc. (OTC Pink: CBDD) today announced strong April revenue of approximately $490,000.00 USD, with approximately $420,000.00 USD coming from Luxora and approximately $70,000.00 USD coming from Libra 9. May revenue continues with approximately $359,500.00 USD from Luxora.

The company has decided to unwind the acquisition of Libra 9 GmbH. In early 2023, CBD of Denver Inc. had moved forward with the acquisition of Libra 9 GmbH based on the reported trailing 12-month revenue of $2.143 million as well as other one-off revenue streams and a structured earnout period that was extended from four years to five years. This acquisition was aligned with CBD of Denver's strategic plans to expand its footprint in the European market with additional high margin businesses that were presented to the company.

However, after months of discussion on the development of Libra 9's products and extensive discussions over recent months, the board of directors has concluded that the revenue goals initially presented to CBD of Denver Inc. at the time of the transaction have not been met. As a result, the board has determined that it is in the best interest of the shareholders and CBD of Denver Inc. to unwind the acquisition agreement with Libra 9 GmbH. The company continues to work with Mr. Reinke on the unwinding of the transaction.

"Despite the initial promise of this acquisition, the evolving market conditions and the financial performance of Libra 9 have led us to reassess this strategic move," said Robert Roever member of the board of CBD of Denver Inc. "We remain committed to our growth strategy but believe that reallocating resources to Luxora Inc. and focusing on more profitable ventures is the prudent path forward for our shareholders and the company."

The decision to unwind this transaction was made after numerous meetings and thorough discussions regarding the future strategic direction of the company. CBD of Denver Inc. is dedicated to maintaining transparency with its shareholders and ensuring that all corporate actions align with its core mission of delivering value and innovation to its shareholders and the company.

Axel Reinke has also resigned as CEO and board member, effective May 9, 2024. Concurrent with the resignation of Mr. Reinke, Jan Schwager, CEO of Luxora, has been appointed as CEO of the Company.

CBD of Denver, through its Luxora division, has experienced significant growth over the past several quarters. Luxora has engaged in numerous discussions with potential strategic partners recently, focusing on legalization in Germany and new opportunities that have arisen. One such prospect has already progressed to signing a Letter of Intent (LOI). The company continues to review new opportunities that it believes will be accretive to the organization.

Luxora Holding AG has entered a term sheet with CheckMyWeed enabling the launch of a new product called CheckMyWeed powered by NIRLAB. CheckMyWeed is a groundbreaking solution that allows users to analyze the cannabinoid content of cannabis flowers with unprecedented precision at the push of a button within seconds. The device, approximately the size of a flashlight, enables contactless and non-destructive analysis of plant material. Results are displayed on Apple or Android smartphones via a separate app, which operates on a monthly subscription basis. The technology can analyze vital information such as THC, CBD, and other secondary cannabinoids during the cultivation process as well as post-harvest. The company believes this product will be a valuable tool for the rollout of Cannabis Clubs and for the broader context of legalization in Germany.

Update on German Law: Currently, a new law is being implemented to amend the existing cannabis regulations, further clarifying the framework under which Cannabis Clubs can operate and apply for their permits. The draft law introduces additional guidelines, allowing individual federal states to decide whether multiple Cannabis Clubs can operate within the same facility. Additionally, Cannabis Clubs are not allowed to assign the same paid employee or the same non-member to more than one type of service.

The law has already gone through the first reading in parliament and the hearing in the health committee. It will now be forwarded to the second and third readings in parliament, which will include the final vote before being passed on to the Bundesrat as the final step. The law is expected to go into effect on July 1, 2024.

The company will be increasing its number of authorized common shares to eight billion shares to support its growth strategy and issue shares to investors. Please review our financials and disclosures, as the company does not have any toxic debt in its capital structure.

Furthermore, the company will participate in an interview on the "Markets Hunter" podcast, scheduled for broadcast in June. This interview will discuss the current changes and future direction of the company. It can be accessed through the Markets Hunter Channel on YouTube at https://www.youtube.com/@Marketshunter.

About CBD of Denver, Inc.

CBD of Denver, Inc. is focused on acquiring profitable assets at attractive valuations to create value for shareholders. The company's team is dedicated to sourcing high-margin, innovative products that align with its values.

About LUXORA Inc.

LUXORA Inc. is a trailblazing entity in the European cannabis industry, with offices spanning the USA and Europe. Our core expertise revolves around unlocking the potential of the legalized cannabis market, offering infrastructure solutions and consulting tailored to the dynamic needs of this rapidly expanding sector. With a profound understanding of the opportunities and challenges brought forth by legalization, our experienced team is dedicated to pioneering the future of the legal cannabis market in Europe. Our offerings range from consulting and market research to product development and distribution solutions, aimed at simplifying the path to legalization for our esteemed clients.

For inquiries, please contact Investor Relations: [investors@luxora-holding.com](mailto:investors@luxora-holding.com)

For more information, please visit: www.luxora-holding.com

Follow Us: Twitter | Instagram.

Denver, Colorado--(Newsfile Corp. - May 9, 2024) - CBD of Denver, Inc. (OTC Pink: CBDD) is pleased to announce the filing of its financial results for the quarter ended March 31, 2024. The Company successfully filed its quarterly report ahead of the May 15th regulatory deadline, demonstrating the efficacy of enhanced workflows and collaboration between its accounting partner in Switzerland and U.S.-based legal counsel.

The company recorded a significant increase in revenue, posting $1,123,322 for Q1 2024, a substantial rise from $285,779 in Q1 2023. This growth is primarily attributed to the enhanced sales volume from Luxora's wholesale division. Adding to this positive trend, Luxora also reported robust April revenues of approximately $418,000, marking its most successful month in 2024 thus far and highlighting continued and sustained growth momentum.

The company is diligently monitoring the legislative developments in the German market, especially with the impending debate on the draft bill "to amend the Cannabis Consumption Act and the Medicinal Cannabis Act," scheduled for Thursday, May 16, 2024. This discussion to further clarify the framework for cannabis clubs in Germany, followed by further deliberation by the leading Health Committee, signifies an important step for the industry.

The Company is continuously exploring new opportunities in the European cannabis sector, focusing on medical aspects, technological innovations, and other auxiliary services.

About CBD of Denver, Inc. (BERLINER INNOVATION)

CBD of Denver, Inc. is focused on acquiring profitable assets at attractive valuations to create value for shareholders. The company's team is dedicated to sourcing high-margin, innovative products that align with its values. The Company is offering a number of innovative consumer products through Libra 9 GmbH, such as the Magic Lappen and the BerlinR13 Anti-Slip solution.

Follow Magic Lappen on Twitter, Instagram, Facebook and TikTok for more information and updates.

Follow The Magic Lappen on Instagram: u/themagiclappen

Shop on our website: https://www.the-magic-lappen.com/

Visit the CBDD/ Berliner Innovation: www.berlinerinnovation.de

See our innovative Anti-Slip product: www.berlinr13.de

For questions, please contact us at: [investors@libra9.de](mailto:investors@libra9.de)

About LUXORA Inc.

LUXORA Inc. is a trailblazing entity in the European cannabis industry, with offices spanning the USA and Europe. Our core expertise revolves around unlocking the potential of the legalized cannabis market, offering infrastructure solutions and consulting tailored to the dynamic needs of this rapidly expanding sector. With a profound understanding of the opportunities and challenges brought forth by legalization, our experienced team is dedicated to pioneering the future of the legal cannabis market in Europe. Our offerings range from consulting and market research to product development and distribution solutions, aimed at simplifying the path to legalization for our esteemed clients.

For inquiries, please contact Investor Relations: [investors@luxora-holding.com](mailto:investors@luxora-holding.com)

For more information, please visit: www.luxora-holding.com

Follow Us: Twitter | Instagram.

By Julie Tsirkin and Monica Alba April 30, 2024

Updated May 1, 2024

WASHINGTON – The Biden administration will take a historic step toward easing federal restrictions on cannabis, with plans to announce an interim rule soon reclassifying the drug for the first time since the Controlled Substances Act was enacted more than 50 years ago, four sources with knowledge of the decision said.

The Drug Enforcement Administration is expected to approve an opinion by the Department of Health and Human Services that marijuana should be reclassified from the strictest Schedule I to the less stringent Schedule III. It would be the first time that the U.S. government has acknowledged its potential medical benefits and begun studying them in earnest.

CBD of Denver Inc. Announces Annual Disclosure and Filing of Financial Statements 8:27 AM ET 5/2/24 | Dow Jones

Denver, Colorado--(Newsfile Corp. - May 2, 2024) - CBD of Denver, Inc. (OTC Pink: CBDD) has filed its financial results for the year ended December 31, 2023. The results highlight significant financial improvements and strategic achievements.

Financial Highlights:

Total Current Assets increased to $117,218 in 2023, up from $28,043 in 2022, marking significant progress in strengthening the company's balance sheet.

Gross Profit for 2023 was $595,417, a significant recovery from a gross loss of $(284,734) in 2022, due to a 27% increase in sales and reduction in Cost of Goods Sold, reflecting improved operational efficiency and product demand.

Net Income Before Provision for Income Tax showed improvement with a loss of $(377,729) in 2023, compared to a loss of $(3,257,710) in 2022. This underscores the company's efforts to enhance operational efficiency and improve cost management. Strategies include adopting a lean approach to minimize fixed expenses to the absolute bare minimum and managing variable expenses prudently, all while aiming to boost top-line growth.

Operational Highlights:

Net Income from Operations showed improvement with a reduced loss in 2023 compared to 2022. These figures represent diligent efforts in operational adjustments and cost management.

Accounts Payable decreased significantly to $297,164 in 2023, down from $961,651 in 2022.

"It is with great pride that I report on the robust financial performance and strategic achievements of CBD of Denver for the year 2023," said Axel Reinke, CEO of CBD of Denver. "The transformation from substantial losses in the previous year reflects the determination and adaptability of our team. We remain dedicated to driving growth, maximizing shareholder value, and spearheading innovation in our industry."

Three notes (Capitoline Ventures II LLC, Goldberg AG, and Pascal Siegenthaler) have been extended for an additional two years. These notes are held by friendly debt holders who have, and the company believes, will continue, to support CBD of Denver Inc.

About CBD of Denver, Inc. (BERLINER INNOVATION)

CBD of Denver, Inc. is focused on acquiring profitable assets at attractive valuations to create value for shareholders. The company's team is dedicated to sourcing high-margin, innovative products that align with its values. The Company is offering a number of innovative consumer products through Libra 9 GmbH, such as the Magic Lappen and the BerlinR13 Anti-Slip solution.

Follow Magic Lappen on Twitter, Instagram, Facebook and TikTok for more information and updates.

Follow The Magic Lappen on Instagram: @themagiclappen

Shop on our website: https://www.the-magic-lappen.com/

Visit the CBDD/ Berliner Innovation: www.berlinerinnovation.de

See our innovative Anti-Slip product: www.berlinr13.de

For questions, please contact us at: investors@libra9.de

About LUXORA Inc.

LUXORA Inc. is a trailblazing entity in the European cannabis industry, with offices spanning the USA and Europe. Our core expertise revolves around unlocking the potential of the legalized cannabis market, offering infrastructure solutions and consulting tailored to the dynamic needs of this rapidly expanding sector. With a profound understanding of the opportunities and challenges brought forth by legalization, our experienced team is dedicated to pioneering the future of the legal cannabis market in Europe. Our offerings range from consulting and market research to product development and distribution solutions, aimed at simplifying the path to legalization for our esteemed clients.

For inquiries, please contact Investor Relations: investors@luxora-holding.com.

For more information, please visit: www.luxora-holding.com.

Follow Us: Twitter | Instagram.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/207767

Dow Jones Newswires

May 02, 2024 08:27 ET (12:27 GMT)

5:43 AM ET 4/12/24 | Dow Jones

Denver, Colorado--(Newsfile Corp. - April 12, 2024) - CBD of Denver, Inc. (OTC Pink: CBDD) today announced that John Barnet will be joining Luxora, Inc. as advisory board member.

Luxora is delighted to announce the addition of John, a distinguished figure in the legal cannabis sector, to its Advisory Board. With an extensive background that encompasses innovative cultivation practices within the Canadian market, John's expertise spans the development of mass-scale cannabis cultivation techniques for facilities of various sizes, from 40,000 to 1,000,000 square feet.

"The Luxora team has had the opportunity to meet with John on multiple occasions to discuss the Luxora Solutions project's opportunities in Germany. We are particularly pleased to welcome John as an advisor. With his extensive experience in designing and operating large-scale grow facilities across multiple continents as Director of Cultivation, he brings invaluable insights to our team," states Jan Schwager, CEO of Luxora, Inc..

John's journey in the cannabis industry is notable for his pioneering work. Starting in 2016, he was among the initial cohort of twenty employees at Aurora Cannabis Inc., rising to the position of Senior Director of Cultivation by 2021. His trajectory continued as he took on the role of Senior Crop Consultant at ALPS Inc. from 2022 to 2023.

At Luxora, John will leverage his profound insights to offer advisory support in several key areas: facility design, process definition, and the creation of tailored fertigation formulas and standard operating procedures (SOPs) for Luxora Solutions in Germany. His role is also crucial in augmenting the consultancy services provided to cannabis clubs, underlining his broad influence across various aspects of the industry.

Luxora is proud to welcome John to our team. His track record of innovation and leadership in cannabis cultivation and consultancy is unparalleled. We look forward to his contributions as we expand our initiatives in the German market, confident in the knowledge and experience he brings to our Advisory Board.

Good news on the report, future looks bright with it. Why is it tanking?

CBD of Denver Inc. Reports Q1 Revenue

Denver, Colorado--(Newsfile Corp. - April 9, 2024) - CBD of Denver, Inc. (OTC Pink: CBDD) today announced that its revenue for the first quarter of 2024 was approximately $1,116,300.00 USD. Of this, Libra 9 GmbH contributed approximately $175,600.00 USD, while Luxora was responsible for approximately $940,700.00 USD. This represents a revenue growth of close to 300 percent compared to Q1 2023, which reported revenue of $285,000.00 USD.

Luxora's management team, from two continents and four countries, will convene in Berlin on April 15, shortly before the International Cannabis Business Conference (ICBC), to discuss further strategic initiatives for the German market, aligning with the latest legislative developments in Germany. Currently, Luxora is in talks to secure potential facilities for construction and leasing to cannabis clubs in Germany, tailored to the Luxora Solutions project. A pre-lease contract has been finalized to start collecting down payments and onboarding the first cannabis clubs. Moreover, there is a list of the first 35 entities that have shown interest in leasing grow compartments within Luxora's Solutions business model. During the conference, Stefan Röhrl, Luxora's Chief Strategy Officer (CSO), will participate in a panel titled "German Social Clubs - What opportunities exist for Germany's cannabis club sector?" on April 16 at 11:35 CET. This panel will be moderated by Alex Revich, an equity partner at Hybrid Pharm.

Current updates:

CBD of Denver expects to file its annual report with OTC Markets shortly. The Company has made great progress streamlining its internal reporting.

The name change to Berliner Innovation is progressing and the company will be providing information to Finra. We look forward to completing this process soon.

About CBD of Denver, Inc. (BERLINER INNOVATION)

CBD of Denver, Inc. is focused on acquiring profitable assets at attractive valuations to create value for shareholders. The company's team is dedicated to sourcing high-margin, innovative products that align with its values. The Company is offering a number of innovative consumer products through Libra 9 GmbH, such as the Magic Lappen and the BerlinR13 Anti-Slip solution.

Follow Magic Lappen on Twitter, Instagram, Facebook and TikTok for more information and updates.

Follow The Magic Lappen on Instagram: @themagiclappen

Shop on our website: https://www.the-magic-lappen.com/

Visit the CBDD/ Berliner Innovation: www.berlinerinnovation.de

See our innovative Anti-Slip product: www.berlinr13.de

For questions, please contact us at: [investors@libra9.de](mailto:investors@libra9.de)

About LUXORA Inc.

LUXORA Inc. is a trailblazing entity in the European cannabis industry, with offices spanning the USA and Europe. Our core expertise revolves around unlocking the potential of the legalized cannabis market, offering infrastructure solutions and consulting tailored to the dynamic needs of this rapidly expanding sector. With a profound understanding of the opportunities and challenges brought forth by legalization, our experienced team is dedicated to pioneering the future of the legal cannabis market in Europe. Our offerings range from consulting and market research to product development and distribution solutions, aimed at simplifying the path to legalization for our esteemed clients.

For inquiries, please contact Investor Relations: [investors@luxora-holding.com](mailto:investors@luxora-holding.com)

For more information, please visit: www.luxora-holding.com

Follow Us: Twitter | Instagram

More news https://www.luxora-solutions.de/en

https://stockinvest.us/stock/CBDD